1 completed, 1 recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow ITP: new trials by email Literature Review of ITP trials Research Report on ITP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) Efgartigimod IV, Placebo IV - Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia | Phase 2 / Phase 3 | Recruiting | argenx | 24 | 2025-10-20 | 2026-10-16 |
| Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone High dose Dexamethasone pulses, Prednisone - ITP, Croticosteroid Therapy | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 36 | 2016-10-01 | 2017-09-18 |
Purpura, Thrombocytopenic, Idiopathic (1)
Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cytopenia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Purpura (1) · Purpura, Thrombocytopenic (1) · Signs and Symptoms (1) · Skin Manifestations (1)
Prednisone (1)
Isfahan University of Medical Sciences (1) · argenx (1)
France (1) · Germany (1) · Iran (1) · Italy (1) · Japan (1) · Lithuania (1) · Poland (1) · Romania (1) · Serbia (1) · Spain (1) · United Kingdom (1)
2025 (1)